Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
23/26/23	₹128.43	-2.00%	9,957
22/26/22	₹131.05	-2.00%	11,514
21/26/21	₹133.72	-4.99%	1,06,424
19/26/19	₹140.75	+4.53%	1,96,125
16/26/16	₹134.65	+5.00%	1,04,608

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 23/10/2026			5-day change	1st Jan Change
128.43 ^INR	-2.00%		-4.62%	+83.47%

06/10	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
29/09	Valiant Laboratories Limited Announces Change in Registered Office Address	CI

Market Cap	697.54Cr 7.35Cr 6.56Cr 6.06Cr 5.49Cr 10Cr 10Cr 73Cr 29Cr 365.46Cr 28Cr 27Cr 1.15TCr	P/E 2025	-150x	P/E 2026	-79.4x
Enterprise Value	710.6Cr 7.49Cr 6.68Cr 6.18Cr 5.6Cr 10Cr 11Cr 74Cr 29Cr 372.31Cr 28Cr 27Cr 1.17TCr	EV / Sales 2025	2.83x	EV / Sales 2026	1.24x
Free-Float	23.22%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

06/10	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
29/09	Valiant Laboratories Limited Announces Change in Registered Office Address	CI
10/08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
10/08	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
20/05	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
14/05	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
23/04	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
11/02	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
15/01	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
12/11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
07/11	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/25/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
09/25/09	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI

Valiant Laboratories Limited Share Price

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news: Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	-2.00%
1 week	-4.62%
Current month	+1.74%
1 month	+4.29%
3 months	+108.83%
6 months	+69.68%
Current year	+83.47%

1 week	128.43	141.38
1 month	113	141.38
Current year	49.51	141.38
1 year	49.51	141.38
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	44	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	-2.00%	-4.62%	+47.86%	-26.63%	7.35Cr
ECOLAB INC.	-1.29%	-0.12%	+4.08%	+80.05%	8.09TCr
GIVAUDAN SA	+0.45%	+1.99%	+12.89%	+41.40%	4.47TCr
SIKA AG	-2.33%	-1.29%	+2.39%	-16.46%	3.5TCr
HENKEL AG & CO. KGAA	-0.13%	-0.40%	+9.82%	+17.29%	3.38TCr
NOVONESIS A/S	+0.52%	+5.87%	+17.87%	+71.78%	3.36TCr
FUJIFILM HOLDINGS CORPORATION	-0.38%	-1.22%	-4.29%	+21.94%	2.58TCr
EMS-CHEMIE HOLDING AG	-0.85%	-0.96%	+52.75%	+44.55%	2.48TCr
DUPONT DE NEMOURS, INC.	+1.07%	+4.68%	-43.81%	-37.48%	1.84TCr
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	+1.37%	-5.08%	+25.44%	+10.46%	1.63TCr
Average	-0.36%	-0.28%	+12.50%	+20.69%	3.14TCr
Weighted average by Cap.	-0.45%	+0.44%	+8.71%	+37.94%

	2025	2026
Net sales	133.38Cr 1.41Cr 1.25Cr 1.16Cr 1.05Cr 1.97Cr 2Cr 14Cr 5.52Cr 70Cr 5.27Cr 5.16Cr 220.32Cr	237.47Cr 2.5Cr 2.23Cr 2.06Cr 1.87Cr 3.5Cr 3.56Cr 25Cr 9.83Cr 124.42Cr 9.39Cr 9.19Cr 392.25Cr
Net income	-2.2Cr -2L -2L -2L -2L -3L -3L -23.02L -9L -1.15Cr -9L -9L -3.64Cr	-3.27Cr -3L -3L -3L -3L -5L -5L -34.17L -13.53L -1.71Cr -12.92L -12.64L -5.4Cr
Net Debt	45Cr 47.71L 42.61L 39.36L 35.67L 66.73L 67.83L 4.74Cr 1.88Cr 24Cr 1.79Cr 1.75Cr 75Cr	13Cr 13.76L 12.29L 11.35L 10.29L 19.25L 19.56L 1.37Cr 54.08L 6.84Cr 51.64L 50.54L 22Cr